In
this work, based on electrochemiluminescence (ECL) technology
and self-assembled portable disease detection chips, a bioactivity-maintained
sensing platform was developed for the quantitative detection of neuron-specific
enolase. First, we prepared Fe3O4@MoS2 nanocomposites as an efficient catalyst to accelerate the reduction
of persulfate (S2O8
2–). Specifically,
abundant sulfate radicals (SO4
•–) were generated because of cyclic conversion between Fe2+ and Fe3+. Meanwhile, MoS2 nanoflowers with
a high specific surface area could not only load more Fe3O4 but also solve its agglomeration problem, which greatly
improved the catalytic efficiency. Moreover, a biosensor chip was
constructed by standard lithography processes for disease detection,
which had good sensitivity and portability. According to the above
strategies, the developed portable sensing platform played the part
of promoting the practical application of bioanalysis in early tumor
screening and clinical diagnosis. In addition, we developed a short
peptide ligand (NARKFYKG, NAR) to avoid the occupation of antigen
binding sites by specifically connecting to Fc fragments in antibodies.
Thus, the binding efficiency of antibodies and the activity of biosensors
were improved due to the introduction of NAR.